Healthcare Market Update - October 2018
In our latest Healthcare Market Update, we look at the positive results from a CAR-T proof-of-concept trial in solid cancer, the IND for a second CRISPR-based therapy and the NASH battlefield.
In our latest Healthcare Market Update, we look at the positive results from a CAR-T proof-of-concept trial in solid cancer, the IND for a second CRISPR-based therapy and the NASH battlefield.